These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy.
    Author: Dou QP, Smith DM, Daniel KG, Kazi A.
    Journal: Prog Cell Cycle Res; 2003; 5():441-6. PubMed ID: 14593738.
    Abstract:
    The ubiquitin/proteasome-dependent protein degradation pathway plays an essential role in both up-regulation of cell proliferation and down-regulation of cell death in human cancer cells. The idea that proteasome function is required for tumor cell survival has prompted the design, synthesis and evaluation of various pharmacological proteasome inhibitors. Both in vitro and in vivo experimental and clinical results have demonstrated the potential use of proteasome inhibitors as novel anticancer drugs.
    [Abstract] [Full Text] [Related] [New Search]